Mantle Cell Lymphoma (MCL) Treatment Patterns, Healthcare Resource Use (HRU), and Costs in the United States

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2015.04.105 ◽

2015 ◽

Vol 15 ◽

pp. S226 ◽

Author(s):

Chris Kozma ◽

Terra Slaton ◽

R Scott McKenzie ◽

Brad Schenkel ◽

Lorie Ellis

Keyword(s):

United States ◽

Mantle Cell Lymphoma ◽

Resource Use ◽

Healthcare Resource ◽

Cell Lymphoma ◽

The United States ◽

Treatment Patterns ◽

Healthcare Resource Use ◽

Download Full-text

Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States

Cancer Medicine ◽

10.1002/cam4.2559 ◽

2019 ◽

Vol 8 (17) ◽

pp. 7174-7185 ◽

Author(s):

Shaum M. Kabadi ◽

Aimee Near ◽

Keiko Wada ◽

Chakkarin Burudpakdee

Keyword(s):

United States ◽

Adverse Events ◽

Resource Use ◽

Healthcare Resource ◽

Cell Lymphoma ◽

The United States ◽

Treatment Patterns ◽

Healthcare Resource Use ◽

Mantle Cell ◽

Insured Patients

Download Full-text

Real‐World Characteristics, Treatment Patterns, Healthcare Resource Use and Costs of Patients with Diffuse Large B‐Cell Lymphoma in the United States

The Oncologist ◽

10.1002/onco.13721 ◽

2021 ◽

Author(s):

Xiaoqin Yang ◽

François Laliberté ◽

Guillaume Germain ◽

Monika Raut ◽

Mei Sheng Duh ◽

...

Keyword(s):

United States ◽

Resource Use ◽

Healthcare Resource ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

The United States ◽

Treatment Patterns ◽

Healthcare Resource Use ◽

Large B Cell Lymphoma ◽

Download Full-text

Adverse events, resource use, and economic burden associated with mantle cell lymphoma: a real-world assessment of privately insured patients in the United States

Leukemia & Lymphoma ◽

10.1080/10428194.2018.1509320 ◽

2018 ◽

Vol 60 (4) ◽

pp. 955-963 ◽

Author(s):

Ravi K. Goyal ◽

Saurabh P. Nagar ◽

Shaum M. Kabadi ◽

James A. Kaye ◽

Brian Seal ◽

...

Keyword(s):

United States ◽

Adverse Events ◽

Mantle Cell Lymphoma ◽

Resource Use ◽

Economic Burden ◽

Cell Lymphoma ◽

The United States ◽

Mantle Cell ◽

Insured Patients

Download Full-text

Treatment patterns, comorbidities, healthcare resource use, and associated costs by line of chemotherapy and level of comorbidity in patients with newly-diagnosed Merkel cell carcinoma in the United States

Journal of Medical Economics ◽

10.1080/13696998.2018.1517089 ◽

2018 ◽

Vol 21 (12) ◽

pp. 1159-1171 ◽

Author(s):

Mairead Kearney ◽

Katia Thokagevistk ◽

Emmanuelle Boutmy ◽

Murtuza Bharmal

Keyword(s):

United States ◽

Cell Carcinoma ◽

Merkel Cell Carcinoma ◽

Resource Use ◽

Healthcare Resource ◽

The United States ◽

Treatment Patterns ◽

Merkel Cell ◽

Newly Diagnosed ◽

Healthcare Resource Use

Download Full-text

Treatment patterns and outcomes among mantle cell lymphoma patients treated with ibrutinib in the United States: a retrospective electronic medical record database and chart review study

British Journal of Haematology ◽

10.1111/bjh.16922 ◽

2020 ◽

Author(s):

Jeff Sharman ◽

Shaum M. Kabadi ◽

Jamyia Clark ◽

David Andorsky

Keyword(s):

United States ◽

Mantle Cell Lymphoma ◽

Chart Review ◽

Cell Lymphoma ◽

The United States ◽

Treatment Patterns ◽

Mantle Cell ◽

Review Study ◽

Electronic Medical Record Database ◽

Medical Record Database

Download Full-text

Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States

Journal of Medical Economics ◽

10.1080/13696998.2021.1908001 ◽

2021 ◽

pp. 1-1

Author(s):

Xiaoqin Yang ◽

François Laliberté ◽

Guillaume Germain ◽

Monika Raut ◽

Mei Sheng Duh ◽

...

Keyword(s):

United States ◽

B Cell ◽

Resource Utilization ◽

Healthcare Resource ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

The United States ◽

Healthcare Resource Utilization ◽

Treatment Patterns

Download Full-text

Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States

Journal of Medical Economics ◽

10.1080/13696998.2021.1894158 ◽

2021 ◽

Vol 24 (1) ◽

pp. 421-431

Author(s):

Claire L. Simons ◽

Daniel Malone ◽

Michael Wang ◽

Gregory A. Maglinte ◽

Tim Inocencio ◽

...

Keyword(s):

United States ◽

Cost Effectiveness ◽

Mantle Cell Lymphoma ◽

Cell Lymphoma ◽

The United States ◽

Adult Patients ◽

Car T ◽

Download Full-text

PCN71 Budget IMPACT Analysis of Zanubrutinib for the Treatment of Adult Patients with Mantle Cell Lymphoma WHO Have Received at Least One PRIOR Therapy from the Payer Perspective in the United States

Value in Health ◽

10.1016/j.jval.2020.08.208 ◽

2020 ◽

Vol 23 ◽

pp. S434

Author(s):

R. Liu ◽

Y.C. Yeh ◽

K. Yang ◽

X. Gao ◽

M. Balk ◽

...

Keyword(s):

United States ◽

Mantle Cell Lymphoma ◽

Impact Analysis ◽

Budget Impact ◽

Cell Lymphoma ◽

The United States ◽

Adult Patients ◽

Prior Therapy ◽

Payer Perspective ◽

Download Full-text

CV3 VARIATIONS IN HEALTHCARE RESOURCE USE AND EXPENDITURES BY AGE IN PATIENTS UNDER AGE 65 NEWLY DIAGNOSED WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT) IN THE UNITED STATES

Value in Health ◽

10.1016/j.jval.2019.04.036 ◽

2019 ◽

Vol 22 ◽

pp. S38

Author(s):

N.C. Sacks ◽

K.A. Everson ◽

P.L. Cyr ◽

M. Emden ◽

M. Preib ◽

...

Keyword(s):

United States ◽

Supraventricular Tachycardia ◽

Resource Use ◽

Healthcare Resource ◽

The United States ◽

Paroxysmal Supraventricular Tachycardia ◽

Newly Diagnosed ◽

Healthcare Resource Use

Download Full-text

PMU33 THE IMPACT OF HIGH RISK AND CHRONIC OPOID USE AMONG COMMERCIALLY INSURED ENDOMETRIOSIS PATIENTS ON HEALTHCARE RESOURCE USE AND COSTS IN THE UNITED STATES

Value in Health ◽

10.1016/j.jval.2020.04.808 ◽

2020 ◽

Vol 23 ◽

pp. S239

Author(s):

S. Estes ◽

A.M. Soliman ◽

M. Zivkovic ◽

X. Zhu ◽

D. Chopra

Keyword(s):

United States ◽

High Risk ◽

Resource Use ◽

Healthcare Resource ◽

The United States ◽

Healthcare Resource Use ◽

Download Full-text